UAE Scientists Use AI to Identify Potential Blood Cancer Drug Class
Researchers in the UAE have leveraged artificial intelligence to discover a new class of potential blood cancer drugs, known as PROTACs. These molecules are designed to target and destroy specific proteins that promote malignant cell growth in certain leukemias and lymphomas. This AI-driven approach, detailed in the Journal of Medicinal Chemistry, represents a significant advancement in accelerating drug development timelines and offers a promising new avenue for cancer therapy.